Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays.
about
Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@ast
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@en
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@nl
type
label
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@ast
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@en
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@nl
prefLabel
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@ast
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@en
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@nl
P2093
P2860
P1476
Discovery of potent, orally ac ...... ctivity in preclinical assays.
@en
P2093
Fen-Lai Tan
Jian-Zhong Shen-Tu
Lan-Juan Li
Lie-Ming Ding
Xin-Shan Kang
Yun-Qing Qiu
P2860
P304
P577
2012-04-02T00:00:00Z